Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Short-term Investments (2024 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Short-term Investments for 2 consecutive years, with $20.3 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Short-term Investments changed N/A year-over-year to $20.3 million, compared with a TTM value of $20.3 million through Mar 2025, changed N/A, and an annual FY2024 reading of $23.0 million, changed N/A over the prior year.
  • Short-term Investments was $20.3 million for Q1 2025 at Kiora Pharmaceuticals, down from $23.0 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $23.4 million in Q3 2024 and bottomed at $20.3 million in Q1 2025.